Pr Shamil Louaya
Ophthalmology Department, OEDMH, BIOMCI Lab, FMPA, UIZ, Agadir, Morocco
Dr Rachid Tahiri
Clinique de la Vision de Casablanca & Centre Hospitalier d’Avranches Granville
Dr Otman Sandali
Clinique de la Vision de Casablanca & Clinique Guillaume de Varye, Bourges. · Casablanca · Maroc
La rubrique des Brèves propose une revue de la littérature synthétique pour rester à jour et ne rien manquer des dernières innovations, techniques chirurgicales et études cliniques majeures. Nos lecteurs y retrouvent des articles récents publiés dans des revues internationales à fort facteur d’impact.
Nitzan I, Eshel Y, Shlomov T, et al. Tetracyclines and Risk of Proliferative Vitreoretinopathy after Rhegmatogenous Retinal Detachment. Ophthalmol Retina. 2026. DOI : 10.1016/j.oret.2026.04.017
Carlà MM, Oreste G, Cusato M, et al. Perforating Scleral Vessels in High Myopia: Overview of Imaging Features, Clinical Implications, and Future Directions. Retina. 2026;46:772-782.
Wang Y, Ishida T, Wang Z, et al. Multimodal Artificial Intelligence for Predicting 3- and 5-Year Risks of Myopic Choroidal Neovascularization in High Myopia. Ophthalmol Retina. 2026;10(6):651-660. DOI : 10.1016/j.oret.2026.02.003
Nawrocka ZA, Nawrocki J. Ten-Year Follow-Up after Vitrectomy with the Inverted Internal Limiting Membrane Flap Technique for Full-Thickness Macular Hole. Ophthalmol Retina. 2026;10(6):606-614. DOI : 10.1016/j.oret.2026.02.004
Muste JC, Schulgit MJ, Perkins S, et al. Outcomes and Complications of Pars Plana Vitrectomy for Nonclearing Vitreous Hemorrhage Without Tractional Elements. Ophthalmol Retina. 2026;10:596-605. DOI : 10.1016/j.oret.2026.01.013
Ni R, Momenaei B, Mahmoudzadeh R, et al. Eyes Achieving Absence of Diabetic Macular Edema and Very Good Vision: A Post Hoc Analysis of DRCR Retina Network Protocol AC. Ophthalmol Retina. 2026;10:615-624. DOI : 10.1016/j.oret.2026.02.009
Singer MA, Wykoff CC, Riemann CD, et al. Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study. Ophthalmology. 2026. DOI : 10.1016/j.ophtha.2026.03.019
Guymer R, Bailey C, Chaikitmongkol V, et al. Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice. Ophthalmol Sci. 2024;4:100442. DOI : 10.1016/j.xops.2023.100442
Ye RZ, Iezzi R. Intraoperative Augmented Reality for Vitreoretinal Surgery Using Edge Computing. J Pers Med. 2025;15:20. DOI : 10.3390/jpm15010020
Gallagher J. Imaging Leukocyte Dynamics in Retinal Disease. Retinal Physician. 4 mai 2026. Présentation de Richard B. Rosen, ARVO 2026.
Staff. Classifications Proposed for Pachychoroid Disease. Review of Optometry, The News Feed. 19 février 2026. Résumé d’une étude publiée dans Eye.
Domalpally A. Video: Artificial Intelligence Dominates ARVO Retina Sessions. Retinal Physician. 29 avril 2026.
Abu Al-Burak S, Alizada A, Sadek K, et al. Pharmacologic Interventions for the Prevention and Treatment of Proliferative Vitreoretinopathy: A Systematic Review and Meta-Analysis. Ophthalmol Retina. 2026. DOI : 10.1016/j.oret.2026.08.002
Sharma A, Regillo CD, Kuppermann BD, et al.; for the PRISM Study Group. Photic retinal injury: Time to move beyond case reports—A PRISM Study Group perspective. Eye. 2026. DOI : 10.1038/s41433-026-04778-6
Moutei H, Abdellaoui M, Chraibi F, Benatiya Andaloussi I. Rétinopexie pneumatique dans le décollement de rétine rhegmatogène : description technique, sélection des patients et gestion des complications. Journal Marocain d’Ophtalmologie. 2025;35:19-25.